Cargando…

Will the real disease gene please stand up?

A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive signals, their follow-up with association studies and discrimination between true and false positive results. Several strategies for overcoming these issues have been devised. Using the Genetic Analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shephard, Neil, John, Sally, Cardon, Lon, McCarthy, Mark I, Zeggini, Eleftheria
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866716/
https://www.ncbi.nlm.nih.gov/pubmed/16451679
http://dx.doi.org/10.1186/1471-2156-6-S1-S66
_version_ 1782133308021276672
author Shephard, Neil
John, Sally
Cardon, Lon
McCarthy, Mark I
Zeggini, Eleftheria
author_facet Shephard, Neil
John, Sally
Cardon, Lon
McCarthy, Mark I
Zeggini, Eleftheria
author_sort Shephard, Neil
collection PubMed
description A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive signals, their follow-up with association studies and discrimination between true and false positive results. Several strategies for overcoming these issues have been devised. Using the Genetic Analysis Workshop 14 simulated dataset, we aimed to apply different analytical approaches and evaluate their performance in discerning real associations. We considered a) haplotype analyses, b) different methods adjusting for multiple testing, c) replication in a second dataset, and d) exhaustive genotyping of all markers in a sufficiently powered, large sample group. We found that haplotype-based analyses did not substantially improve over single-point analysis, although this may reflect the low levels of linkage disequilibrium simulated in the datasets provided. Multiple testing correction methods were in general found to be over-conservative. Replication of nominally positive results in a second dataset appears to be less stringent, resulting in the follow-up of false positives. Performing a comprehensive assay of all markers in a large, well-powered dataset appears to be the most effective strategy for complex disease gene identification.
format Text
id pubmed-1866716
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18667162007-05-11 Will the real disease gene please stand up? Shephard, Neil John, Sally Cardon, Lon McCarthy, Mark I Zeggini, Eleftheria BMC Genet Proceedings A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive signals, their follow-up with association studies and discrimination between true and false positive results. Several strategies for overcoming these issues have been devised. Using the Genetic Analysis Workshop 14 simulated dataset, we aimed to apply different analytical approaches and evaluate their performance in discerning real associations. We considered a) haplotype analyses, b) different methods adjusting for multiple testing, c) replication in a second dataset, and d) exhaustive genotyping of all markers in a sufficiently powered, large sample group. We found that haplotype-based analyses did not substantially improve over single-point analysis, although this may reflect the low levels of linkage disequilibrium simulated in the datasets provided. Multiple testing correction methods were in general found to be over-conservative. Replication of nominally positive results in a second dataset appears to be less stringent, resulting in the follow-up of false positives. Performing a comprehensive assay of all markers in a large, well-powered dataset appears to be the most effective strategy for complex disease gene identification. BioMed Central 2005-12-30 /pmc/articles/PMC1866716/ /pubmed/16451679 http://dx.doi.org/10.1186/1471-2156-6-S1-S66 Text en Copyright © 2005 Shephard et al; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Shephard, Neil
John, Sally
Cardon, Lon
McCarthy, Mark I
Zeggini, Eleftheria
Will the real disease gene please stand up?
title Will the real disease gene please stand up?
title_full Will the real disease gene please stand up?
title_fullStr Will the real disease gene please stand up?
title_full_unstemmed Will the real disease gene please stand up?
title_short Will the real disease gene please stand up?
title_sort will the real disease gene please stand up?
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866716/
https://www.ncbi.nlm.nih.gov/pubmed/16451679
http://dx.doi.org/10.1186/1471-2156-6-S1-S66
work_keys_str_mv AT shephardneil willtherealdiseasegenepleasestandup
AT johnsally willtherealdiseasegenepleasestandup
AT cardonlon willtherealdiseasegenepleasestandup
AT mccarthymarki willtherealdiseasegenepleasestandup
AT zegginieleftheria willtherealdiseasegenepleasestandup